Brief: Aurobindo Pharma Says US FDA Conducted Inspection At Auropeptides From August 17 To August 21
21/08/2026 11:07
BRIEF-Aurobindo Pharma Says US FDA Conducted Inspection At Auropeptides From August 17 To August 21 Aug 21 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
AUROBINDO PHARMA - US FDA CONDUCTED INSPECTION AT AUROPEPTIDES FROM AUGUST 17 TO AUGUST 21
AUROBINDO PHARMA - INSPECTION CONCLUDES WITH ONE OBSERVATION ON FACILITY AND EQUIPMENT MAINTENANCE
AUROBINDO PHARMA - CORRECTIVE ACTION WAS ALREADY INITIATED DURING THE COURSE OF THE INSPECTION
Source text: [ID:]
Further company coverage: ARBN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11